These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11045816)

  • 1. Classification of some active compounds and their inactive analogues using two three-dimensional molecular descriptors derived from computation of three-dimensional convex hulls for structures theoretically generated for them.
    Lin TH; Yu YS; Chen HJ
    J Chem Inf Comput Sci; 2000; 40(5):1210-21. PubMed ID: 11045816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of some active HIV-1 protease inhibitors and their inactive analogues using some uncorrelated three-dimensional molecular descriptors and a fuzzy c-means algorithm.
    Lin TH; Wang GM; Hsu YH
    J Chem Inf Comput Sci; 2002; 42(6):1490-504. PubMed ID: 12444748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional quantitative structure-activity relationship for several bioactive peptides searched by a convex hull-comparative molecular field analysis approach.
    Lin TH; Lin JJ
    Comput Chem; 2001 Sep; 25(5):489-98. PubMed ID: 11513239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative molecular field analysis study on several bioactive peptides using the alignment rules derived from identification of commonly exposed groups.
    Lin TH; Lin JJ; Lu YJ
    Biochim Biophys Acta; 1999 Jan; 1429(2):476-85. PubMed ID: 9989233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional quantitative structure-activity relationship study on cyclic urea derivatives as HIV-1 protease inhibitors: application of comparative molecular field analysis.
    Debnath AK
    J Med Chem; 1999 Jan; 42(2):249-59. PubMed ID: 9925730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional QSAR of human immunodeficiency virus (I) protease inhibitors. 1. A CoMFA study employing experimentally-determined alignment rules.
    Waller CL; Oprea TI; Giolitti A; Marshall GR
    J Med Chem; 1993 Dec; 36(26):4152-60. PubMed ID: 8277496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing a methodology for an inverse quantitative structure-activity relationship using the signature molecular descriptor.
    Visco DP; Pophale RS; Rintoul MD; Faulon JL
    J Mol Graph Model; 2002 Jun; 20(6):429-38. PubMed ID: 12071277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating Multiple Receptor Conformation Docking and Multi Dimensional QSAR for Enhancing Accuracy of Binding Affinity Prediction.
    Radhika V; Jaraf HA; Kanth SS; Vijjulatha M
    Curr Comput Aided Drug Des; 2017; 13(2):127-142. PubMed ID: 28103770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational studies on HIV-1 protease inhibitors: influence of calculated inhibitor-enzyme binding affinities on the statistical quality of 3D-QSAR CoMFA models.
    Jayatilleke PR; Nair AC; Zauhar R; Welsh WJ
    J Med Chem; 2000 Nov; 43(23):4446-51. PubMed ID: 11087569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D-QSAR CoMFA/CoMSIA models based on theoretical active conformers of HOE/BAY-793 analogs derived from HIV-1 protease inhibitor complexes.
    da Cunha EF; Sippl W; de Castro Ramalho T; Ceva Antunes OA; de Alencastro RB; Albuquerque MG
    Eur J Med Chem; 2009 Nov; 44(11):4344-52. PubMed ID: 19616874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional quantitative structure-activity relationship of human immunodeficiency virus (I) protease inhibitors. 2. Predictive power using limited exploration of alternate binding modes.
    Oprea TI; Waller CL; Marshall GR
    J Med Chem; 1994 Jul; 37(14):2206-15. PubMed ID: 8035428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
    Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
    Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DoMCoSAR: a novel approach for establishing the docking mode that is consistent with the structure-activity relationship. Application to HIV-1 protease inhibitors and VEGF receptor tyrosine kinase inhibitors.
    Vieth M; Cummins DJ
    J Med Chem; 2000 Aug; 43(16):3020-32. PubMed ID: 10956210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
    Buolamwini JK; Assefa H
    J Med Chem; 2002 Feb; 45(4):841-52. PubMed ID: 11831895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors: application of molecular field analysis.
    Nunthanavanit P; Anthony NG; Johnston BF; Mackay SP; Ungwitayatorn J
    Arch Pharm (Weinheim); 2008 Jun; 341(6):357-64. PubMed ID: 18442018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative molecular field analysis (CoMFA), topomer CoMFA, and hologram QSAR studies on a series of novel HIV-1 protease inhibitors.
    Heidari A; Fatemi MH
    Chem Biol Drug Des; 2017 Jun; 89(6):918-931. PubMed ID: 27933723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D-quantitative structure-activity relationships of human immunodeficiency virus type-1 proteinase inhibitors: comparative molecular field analysis of 2-heterosubstituted statine derivatives-implications for the design of novel inhibitors.
    Kroemer RT; Ettmayer P; Hecht P
    J Med Chem; 1995 Dec; 38(25):4917-28. PubMed ID: 8523405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclopropane-derived peptidomimetics. Design, synthesis, evaluation, and structure of novel HIV-1 protease inhibitors.
    Martin SF; Dorsey GO; Gane T; Hillier MC; Kessler H; Baur M; Mathä B; Erickson JW; Bhat TN; Munshi S; Gulnik SV; Topol IA
    J Med Chem; 1998 May; 41(10):1581-97. PubMed ID: 9572884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional structure of a simian immunodeficiency virus protease/inhibitor complex. Implications for the design of human immunodeficiency virus type 1 and 2 protease inhibitors.
    Zhao B; Winborne E; Minnich MD; Culp JS; Debouck C; Abdel-Meguid SS
    Biochemistry; 1993 Dec; 32(48):13054-60. PubMed ID: 8241159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyethylamine derivatives as HIV-1 protease inhibitors: a predictive QSAR modelling study based on Monte Carlo optimization.
    Bhargava S; Adhikari N; Amin SA; Das K; Gayen S; Jha T
    SAR QSAR Environ Res; 2017 Dec; 28(12):973-990. PubMed ID: 29072112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.